GLP-1 Agonists and SGLT2 Inhibitors Do Not Increase Autoimmune Risk ...Middle East

Patients with type 2 diabetes prescribed GLP-1 receptor agonists or SGLT2 inhibitors did not have a greater risk of developing autoimmune disease than those prescribed DPP-4 inhibitors. Medscape Medical News

Hence then, the article about glp 1 agonists and sglt2 inhibitors do not increase autoimmune risk was published today ( Monday 04/03/2024 - 02:16 PM ) and is available on Medscape ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( GLP-1 Agonists and SGLT2 Inhibitors Do Not Increase Autoimmune Risk )

Also on site :

• Watch last video of ‘All That’ star Kianna Underwood who died in hit-and-run at 33
• AI cloud startup Runpod hits $120M in ARR — and it started with a Reddit post  
• Tim McGraw Teases New Music With Cryptic Photos & Fans Can't Keep Their Cool